InvestorsHub Logo
Followers 14
Posts 1044
Boards Moderated 0
Alias Born 02/28/2017

Re: None

Monday, 03/20/2017 5:57:20 PM

Monday, March 20, 2017 5:57:20 PM

Post# of 203912
The 8-K mentioned that there was a press-release. Perhaps there will be more information in it. I think the key take away is that they stated that.
1- The results are postive and will warrent moving the product to market.
2- The product will be on the market at some point in Q2 and will begin producing revenue.
3- There are positive treatment results for other illnesses.

Though we all expected and assumed this it is good to hear confirmation though entirely vague on purpose I'm sure.

This is now my thoughts and should be taken as such.

I'm encouraged, not hearing word for nearly a month is a long time when seeing such volent swings. I would expect to hear efficacy results soon with news or shortly after the other applications. Additionally the EFT should be launching within the next 2 weeks. (Again this is only my thoughts on timing but next Wednesday is 6 weeks from announcement and that is the typical timeframe) Couple all this with the conferences this week and next. I could see news droping from several catalyst in a tight sequence which could push PPS rather high.